In 1936, Josephs reported 'a hypoplastic or aplastic type of anaemia confined to a failure of erythropoiesis' in two children. Diamond and Blackfan (1938) gave a more detailed description of the disorder in four children, and emphasized the features of a chronic progressive anaemia beginning early in infancy, with a tendency to moderate depression of the leucocyte and thrombocyte counts, and selective hypoplasia of the red cell precursors in the bone marrow. Several reports of this disease have appeared since (
In 1936, Josephs reported 'a hypoplastic or aplastic type of anaemia confined to a failure of erythropoiesis' in two children. Diamond and Blackfan (1938) gave a more detailed description of the disorder in four children, and emphasized the features of a chronic progressive anaemia beginning early in infancy, with a tendency to moderate depression of the leucocyte and thrombocyte counts, and selective hypoplasia of the red cell precursors in the bone marrow. Several reports of this disease have appeared since (Rinvik, 1940; Kohlbry, 1941; H0yer, 1942; Rubell, 1942; Robson and Sweeney, 1948; Smith, 1949 Smith, , 1953 Smith, , 1959 Palmen and Vahlquist, 1950; Cathie, 1950;  Lelong, Joseph, Polonow- ski, Desmonts and Colin, 1951;  Anderson, 1952; Donnelly, 1953; Aldridge and Kidd, 1953;  Kass and Sundal, 1953; Verger and Leger, 1953; Fisher and Allen, 1953;  Arrowsmith, Burris and Segaloff, 1953; Burgert, Kennedy and Pease, 1954;  Diamond, 1954; Harper and Geikie, 1955; Calvert and Robson, 1956; Sundal, 1956; Pearson and Cone, 1957; Gasser, 1957) , and a total of about 70 cases have been recorded. The reports have conformed to the original descriptions, with the exception that marrow examinations in some instances have revealed normal or increased numbers of normoblasts (Cathie, 1950) . Various terms used to designate this haematological disorder include congenital hypoplastic anaemia, chronic hypoplastic anaemia (Josephs-Diamond-Blackfan type) , erythrogenesis imperfecta, congenital pure red cell anaemia, chronic erythroblastopenia and pure red cell aplasia.
The aetiology is unknown, but is considered by many to rest in a congenital anomaly of the erythron, and the finding of associated congenital anomalies provides some support for this theory. The identification of anthranilic acid in the urine of some children with this disease suggested the presence of an inborn error of tryptophane metabolism; the administration of riboflavin to these patients resulted in a decrease in the excretion of anthranilic acid, but did not alter the haematological status (Altman and Miller, 1953) . Smith (1949) reported the history of a child in whom anaemia developed in early infancy; the maternal antibody titre of anti:A was 1:128,000. It appears that isoimmunization may produce extreme and prolonged depression of the red cell precursors in infancy.
Erythroid hypoplasia, in more general terms, is of varied aetiology, and may occur at all ages. Acute hypoplasia may result from toxic, infective or allergic factors (Gasser, 1957) , and sudden crises may develop in congenital spherocytosis (Owren, 1948) , sickle cell anaemia (Chernoff and Josephson, 1951) , and acquired haemolytic anaemia (Seip, 1955) . Chronic forms of the disease have been attributed to chemical agents and autoimmune processes (Eisemann and Dameshek, 1954; Bonham Carter, Cathie and Gasser, 1954; Bousser, Christol, Dausset, Rampon, Jallut and Mery, 1955) , and have been associated with the presence of thymic tumours. The subject of chronic erythroid hypoplasia in adults has been reviewed by Tsai and Levin (1957) , but this report has included cases only where erythroid proportions were reduced in marrow examinations. Various forms of refractory anaemia with hypercellular bone marrow patterns have been described more recently by Dacie, Smith, White and Mollin (1959) , and Vilter, Jarrold, Will, Mueller, Friedman and Hawkins (1960) . In many instances the aetiology is unknown, and occasionally there have been reports, both in adults and children, of a familial incidence of the disease (Burgert et al., 1954; Diamond, 1954; Loeb, Moore and Dubach, 1953; Wallman, 1956) .
For some time effective therapy of erythroid hypoplasia in infancy and childhood was restricted to the frequent administration of blood transfusions, though spontaneous remissions were known to occur. Three of 12 children cited by Diamond underwent spontaneous remission. From 1953 onwards, reports have been published concerning the successful use of corticotrophin and cortico- was withdrawn, and was associated with partial megaloblastic erythropoiesis, which became more obvious during subsequent steroid therapy. Combined vitamin B15, folic acid, and steroid therapy was associated with correction of the anaemia and improvement in the marrow picture, suggesting that folic acid and vitamin B52 administration were partly responsible for the haematological remission.
Case 4. (Fig. 2) Comment: On five occasions haematological remission occurred during steroid therapy, and the intervals between therapy are probably increasing. It is interesting to note that the last marrow picture during haematological relapse was entirely normal.
Case 5. (Fig. 3) (Fig. 3) (Fig. 4) were not apparent at the stage when steroid therapy was commenced. The anaemia was corrected following steroid administration and recurred when the drug was withheld.
Case 7. (Fig. 5) ul was admitted to this hospital, where investigations revealed a severe anaemia, moderate macrocytosis and reticulocytopenia. Pyuria was detected shortly afterwards, and chemotherapy was successfully prescribed. Bone marrow examinations revealed erythroblastic hypoplasia. After the administration of blood transfusions, prednisolone was given in relatively small quantities (7 5 mg. daily). Moderate anaemia with fluctuating reticulocyte counts was present over the next few months; in January 1959, the dose of prednisolone was increased to 10 mg. daily, and the haemoglobin reached a satisfactory level after several months. The dose of prednisolone was reduced to 2-5 mg. daily in May 1959, but by October anaemia had become marked. An increase in the dose of steroids was followed by correction of the anaemia. At the age of 20 months the child was well, but was less than the tenth centile in height and weight for her age. Blue sclerae and a moderately widely patent fontanelle were noted. The spleen was just palpable. Marrow studies at that stage revealed normal proportions of red cell precursors, some of which showed imperfect haemoglobinization.
Comment: When relatively small amounts of prednisolone (7 5 to 5 mg. daily) were used initially, no impressive rise in haemoglobin values occurred. An increase in dosage was followed by correction of the anaemia over a period of several months. Relapse occurred when only 2 5 mg. of prednisolone were administered daily, and remission followed the institution of larger doses. Evidence for small stature was present before steroids were administered.
Case 8. (Fig. 6) proportions, but defects in normoblastic maturation were still evident. Hepatomegaly was present during the period of observation, splenomegaly being noted only in the initial stages of hospitalization. The child was considerably dwarfed, and weighed only 10 lb. at the age of 7! months. Physical features included short limbs, a short thick neck, and blue sclerae, her appearance resembling that of a child with achondroplasia. However, radiological examination revealed features consistent with a congenital defect of osseous development, but were not typical of any particular form of osteochondrodystrophy. Biochemical tests demonstra.ed no evidence of metabolic bone disease. Comment: The presence of dwarfism and skeletal anomalies suggests that the anaemia is congenital in origin. There is no reason to suspect that the osseous abnormality is affecting red cell production. Steroid therapy was associated with temporary haematological response when the dose was increased, but regression followed, and marrow examinations revealed megaloblastic erythropoiesis. The administration of folic acid was associated with haematological remission and an improvement in the marrow picture. It is possible that the diarrhoea contributed to the folic acid deficiency.
Discussion
Clinical Features. All eight patients presented with severe anaemia at ages varying from 8 weeks to 18 months. Five were female and three were male. Most of the infants had been well previously, apart from progressive pallor, which was noted in the first month of life in three patients. Gastrointestirial symptoms were common when the anaemia became profound. Hepatosplenomegaly was present in three patients (Cases 1, 3 and 8), two of whom (Cases 1 and 3) had received numerous transfusions. Splenomegaly alone was noted at some stage of the disease in two other patients (Cases 6 and 7). The size of the spleen varied, and was not related to the haematological status of the patient. Various physical anomalies were noted in this series, of which the commonest was dwarfism (considerably less ARCHIVES OF DISEASE IN CHILDHOOD than the tenth centile for age in height and weight) in five patients. Three of these five children had additional major anomalies, which included gross urinary tract malformations, exomphalos and a webbed neck, and a generalized skeletal abnormality. Additional features, of doubtful significance, were prominent epicanthic folds in two children, a wide fontanelle in two, blue sclerae in three, and inverted nipples in three children. Aetiology. It was not possible to attribute the anaemia to any extrinsic factors either before or after birth. Only one mother (of Case 6) had any recognizable illness during pregnancy (hyperemesis, toxaemia, and a moderate antepartum haemorrhage) or was exposed to any unusual physico-chemical hazards (chest radiograph at six weeks' gestation; administration of chlorotHiazide and reserpine in the last month of pregnancy). No history of any blood disorders in the families was obtainable. The blood groups of the mothers and patients are included in Table 1 ; it is extremely unlikely that isoimmunization was related to red cell depression in five of these infants (Cases 2, 4, 6, 7 and 8). The associated physical anomalies and the onset of anaemia early in life provide supportive evidence that the disturbance of erythropoiesis is congenital. Although cases have been reported (Burgert et al., 1954; Koass and Sundal, 1953; Rubell, 1942; Diamond and Blackfan, 1938) Cohen, 1957) , and in adult life (Loeb et al., 1953) (Case 5) . Progress marrow studies were performed during steroid therapy in six patients (Cases 2, 3, 4, 5, 7 and 8). Improvement in the marrow picture was noted in four patients (maturation defect less marked in Cases 2 and 5; minor defect in Case 7; normal marrow in Case 4), but in two children (Cases 3 and 8) megaloblastic erythropoiesis and defective normoblastic maturation were detected in the early stages of steroid therapy; these abnormalities were much less prominent two weeks after the additional administration of folic acid or vitamin B12. The bone marrow of three children was examined when haematological relapse occurred following the cessation of steroid administration; in two patients (Cases 4 and 5) the picture was normal, and in one child (Case 3) bizarre normoblasts and occasional megaloblasts were detected in the smears.
Despite these variable features, some pattern emerged during the study of progress marrow examinations. When erythroblastic hypoplasia was present, the morphology of the red cell precursors was usually normal; when erythroid proportions were normal or increased, defects of maturation became apparent, and were usually most marked at the late normoblast stage. The marrow picture improved after the administration of steroids, except in two instances where active erythropoiesis appeared to unmask a latent deficiency of folic ER YTHROID HYPOPLASIA acid or vitamin B2. The administration of these latter agents with steroids was associated with haematological improvement.
Other Laboratory Investigations. Blood urea levels showed transient elevation in two patients (Cases 5 and 7); the results are not available for Case 1. Pyuria was detected in three children (Cases 1, 5 and 7) and was transient in two (Cases 5 and 7); the duration of the anaemia excluded the possibilities of chronic azotaemia or infection as major aetiological factors. The direct Coombs' test was negative and the serum bilirubin level was within normal limits in all patients where these tests were performed (see Table 1 ). A thymic tumour was not detected in the radiological examination of the chest in any patients.
Course and Therapy. Before the advent of steroid therapy, the only consistent benefit in these patients was derived from repeated blood transfusions. Spontaneous remissions occurred in two children (Cases 2 and 3) for periods as long as 14 months. Three patients in this series received more than 25 blood tranfusions, and the remainder at least two. The only child who died (Case 1) received 82 litres of blood, and was found to have extensive haemosiderosis at autopsy.
Steroid therapy was administered to seven patients, and was associated with haematological improvement in all. In one (Case 2), intensive therapy for three weeks failed to induce haematological improvement, and a transfusion was administered. Steroid administration was continued subsequently and she has remained in haematological remission for over 14 months. As spontaneous remissions had occurred previously for periods as long as 14 months, it is possible that her present satisfactory state may be unrelated to steroid therapy. Of the other six patients, none has required transfusions since the time when steroids were first administered, representing intervals of 25, 37, 29, 13, 18 and two and a half months. There is no doubt that steroid therapy was effective, as haematological remission occurred on five occasions in one child (Case 4), and in other patients (Cases 3, 5, 6 and 7) haematological relapse developed when the drug was withdrawn or reduced in dose, to be followed by remission with the reinstitution of adequate therapy. In general, amounts equivalent to 20-30 mg. of prednisolone daily were sufficient to initiate increased red cell production, and such a response was usually evident within four to 11 days. In two patients (Cases 5 and 8) reticulocytosis and a rise in haemoglobin levels did not appear until the dose was increased, when signs of red cell regeneration became apparent in four to five days. The nature of this response suggests that the adjustment of steroid dosage may be critical, although one cannot exclude the possibility that this form of therapy may be required for several weeks to induce effective erythropoiesis.
Numerous megaloblasts were noted in marrow examinations of two children (Cases 3 and 8) during steroid therapy, and reversion to normoblastic erythropoiesis followed the additional administration of folic acid and vitamin B12. In one (Case 8), megaloblastic erythropoiesis was very marked, and a well-defined haematological response followed the use of folic acid. In the other patient (Case 3), megaloblastic erythropoiesis was present to a lesser degree, and haematological improvement after the administration of vitamin B,2, folic acid and prednisolone was less dramatic; moreover, the daily dose of prednisolone administered during the critical period was considerably smaller than that used to induce the first remission two years earlier. The progress of J.A. (Case 8) is similar to that of the child described by Arrowsmith et al. (1953) . When a suboptimal haematological response follows an adequate trial of steroid therapy, it seems advisable to perform further marrow examination to exclude the possibility of megaloblastic erythropoiesis; in Case 8 there was little evidence of macrocytosis in the peripheral blood picture.
Maintenance steroid therapy was usually effective when amounts equivalent to 5-10 mg. of prednisolone .were administered daily, and was associated with no harmful side-effects. Relapse occurred within a few weeks or months in five patients (Cases 3, 4, 5, 6 and 7) when the drug was withdrawn or drastically reduced in dosage, so that prolonged maintenance therapy or intermittent therapy was required. It is likely that the intervals between relapse will become longer with increasing age, as suggested by the progress of Case 4. The longest period of observation of a patient with steroid administration is three years (Case 4).
It has been suggested (Gasser, 1957; Smith, 1959 ) that steroid therapy is of little avail when transfusion haemosiderosis has developed. Only one of the present group of patients could be considered unduly refractory to treatment (Case 2), although only two patients (Cases 2 and 3) had received many blood transfusions before steroid therapy was tried.
A variety of therapeutic regimes was adopted for patients in this series. It is suggested that blood transfusions be administered on the initial two or three occasions when anaemia develops. In doing so, it should be possible to assess the nature of the 360 ARCHIVES OF DISEASE IN CHILDHOOD disease and the intervals between transfusions which may be required. Moreover, haematological remissions may occur for long periods, as illustrated in Cases 2 and 3. Steroid therapy may be instituted subsequently, and it is convenient to continue maintenance treatment for a period of six to 12 months, at the end of which time the patient's requirements may be judged according to haematological progress. High doses of steroids may be required for several weeks to induce haematological remission, and the reason for therapeutic failures in other case reports may be in the administration of inadequate initial doses of steroids. Suboptimal haematological response during steroid therapy should prompt investigation into the possibility of megaloblastic erythropoiesis.
Summary
The literature concerning erythroid hypoplasia in infancy and childhood is reviewed briefly, and the details of eight further patients are presented.
All children developed a severe aregenerative anaemia at ages varying between 8 weeks and 18 months. A high incidence of associated physical anomalies was noted in this series, and included dwarfism, urinary tract malformations, exomphalos, skeletal abnormalities and webbed neck. The association of these anomalies with the onset of anaemia early in life provides supportive evidence that the aetiology of the anaemia rests in a congenital defect of the erythron.
Bone marrow studies revealed considerable variation. Erythroid elements were present in decreased, normal or increased proportions, and defects of normoblastic maturation were noted at some stage in several patients. During steroid therapy the marrow picture showed improvement in four patients, but megaloblastic erythropoiesis became prominent in two other children, and haematological improvement followed the additional administration of folic acid or vitamin B12.
One patient died; the remainder are still living. Spontaneous remission for long periods occurred in two patients before the advent of steroid therapy. Steroids were administered to seven children, of whom six received definite, and one possible benefit.
High doses of steroids for several weeks may be required to induce haematological remission; suboptimal responses to adequate therapy should suggest the possibility of megaloblastic erythropoiesis.
A method of management of these patients is briefly outlined. 
